Table 1 Patient characteristics
No. | % | |
|---|---|---|
Age, years | ||
Median (range) | 68 (31–86) | |
Disease status | ||
Metastatic at diagnosis | 31 | 89 |
Recurrent | 4 | 11 |
Gleason score | ||
6 | 1 | 3 |
7 | 5 | 14 |
8 | 13 | 37 |
9 | 12 | 34 |
10 | 4 | 11 |
Initial PSA, ng/mL | ||
Median (range) | 330.08 (4–50,000) | |
Type of metastases | ||
Bone and/or lymph nodes only | 18 | 51 |
Visceral | 17 | 49 |
Metastatic site | ||
Lymph node | 32 | 91 |
Bone | 34 | 97 |
Lung | 16 | 46 |
Liver | 4 | 11 |
ECOG performance status | ||
0 | 10 | 29 |
1 | 25 | 71 |